News

In a clinical trial, it has been shown that using a combination of two oral medications, TALZENNA and XTANDI, may reduce the risk of prostate cancer progression or death by 37%.

A new targeted drug has sparked remissions in patients with a common form of leukemia and also induced the cancer cells to reveal one of their schemes for resistance.

Researchers have used positron emission tomography and electron microscopy to generate 3D ultra-resolution maps of mitochondrial networks in lung tumors of genetically engineered mice.

Researchers have developed a new and highly accurate radiotherapy treatment for cancer, which may prevent unnecessary damage to healthy tissue and shorten the time that patients spend in hospital.

Researchers have identified a possible genetic driver of uterine corpus endometrial cancer, the fourth deadliest cancer in women.

Digital breast tomosynthesis showed improved breast cancer screening outcomes over screening with standard digital mammography alone in a study of over a million women.

A new study has linked high levels of a gene product, produced by many types of cancer, with an elevated immune response and improved outcomes in a common form of head and neck cancer.

A new study has discovered why breast cancer cells that have spread to the lungs may "wake up" following years of dormancy, and also suggests a strategy that could defuse this mechanism.

Immune cells may be triggered to attack rather than protect a tumor when bacteria is introduced to the tumor microenvironment.

Researchers have identified 10 genetic mutations that can predict the most common type of bladder cancer up to 12 years prior to diagnosis. The study results were presented at the European Association of Urology (EAU) annual Congress in Milan.